NIH to evaluate remdesivir treatment for COVID during pregnancy

WASHINGTON (NEWS10) — The National Institutes of Health (NIH) is funding a study into the effects of prescription remdesivir on those who are both pregnant and COVID-positive. Called “IMPAACT 2032,” the study, conducted at 17 sites in the U.S., will examine how pregnant people metabolize and digest the drug, and whether it poses side effects. […]

Coronavirus Drug and Treatment Tracker - The New York Times

Coronavirus Drug and Treatment Tracker - The New York Times

Baricitinib in Combination with Remdesivir Reduces Time to

COVID, Free Full-Text

Efficacy Data for COVID-19

Pregnancy and COVID-19

Comparative therapeutic efficacy of remdesivir and combination

Remdesivir for the treatment of hospitalized patients with severe

Science Is Answering Questions About COVID-19 and Pregnancy

Covid-19 Research Opens to Little-Studied Group: Pregnant Patients

Two Years into the COVID-19 Pandemic: Lessons Learned

Summary of Guidance for Minimizing the Impact of COVID-19 on

Oral Antivirals for High-Risk COVID-19 Patients